NeurAxis, Inc. entered into a securities purchase agreement for issuance of 1,260,504 series B convertible preferred stock at price of $2.38 per share for gross proceeds of $3,000,000 on November 9, 2023. The transaction will include participation from new investor Flagstaff International, Inc. The aggregate purchase price is to be paid in 15 monthly installments of $200,000 each, commencing on the later of January 10, 2024 or a date after stockholders approve of an amendment to the company?s certificate of incorporation to authorize the creation of the shares. The series B preferred stock is convertible at any time into shares of common stock of the company without any further consideration.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.03 USD | +4.12% | -1.94% | +13.48% |
05-22 | Earnings Flash (NRXS) NEURAXIS Posts Q1 Revenue $646,635 | MT |
05-22 | Neuraxis, Inc. Provides Earnings Guidance for Late 2024 and 2025 | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+13.48% | 19.98M | |
+75.33% | 12.54B | |
-24.19% | 7.39B | |
+6.43% | 6.62B | |
+13.59% | 5.43B | |
+34.82% | 4.81B | |
-14.82% | 4.8B | |
-25.57% | 3.72B | |
-26.93% | 2.76B | |
+49.43% | 2.4B |
- Stock Market
- Equities
- NRXS Stock
- News NeurAxis, Inc.
- NeurAxis, Inc. announced that it expects to receive $3 million in funding from Flagstaff International, Inc